Skip to content
2000
Volume 27, Issue 11
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide with significant clinical and economic implications. The field of antihypertensive treatment already numbers numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve a tailored approach to the individual patient, with genetic modulation playing a key role.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666201106091527
2021-03-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666201106091527
Loading

  • Article Type:
    Review Article
Keyword(s): blood pressure; drug; Hypertension; intervention; novel; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test